Pfizer to Pay $93 Million for Antitrust Claims on Cholesterol Drug Lipitor
Pfizer has agreed to pay $93 million to settle antitrust claims by wholesale drug distributors that slammed the medical giant company for conspiring with India’s Ranbaxy Laboratories to delay sales of less costly generic versions of Lipitor, a cholesterol drug.…


